Endometrioid adenocarcinomas of the uterine corpus in women younger than 50 years of age can be divided into two distinct clinical and pathologic entities based on anatomic location

Cancer

Volumn 92, Issue 10, 2001, Pages 2578-2584

  Hachisuga, Toru ^a,b,c   Fukuda, Koichi ^a,b   Iwasaka, Tsuyoshi ^a,b   Hirakawa, Toshio ^a,c   Kawarabayashi, Tatsuhiko ^c   Tsuneyoshi, Masazumi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Clinicopathology; Corpus mucosa proper; Endometrial carcinoma; Lower uterine segment; Young age

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BODY MASS; CANCER CLASSIFICATION; CANCER GRADING; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOMETRIOID CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MYOMETRIUM; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; UTERUS CANCER;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGE FACTORS; BODY MASS INDEX; DIABETES COMPLICATIONS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYPERTENSION; MIDDLE AGED; NEOPLASM INVASIVENESS; PARITY; POLYCYSTIC OVARY SYNDROME; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0035889951     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20011115)92:10<2578::AID-CNCR1610>3.0.CO;2-V     Document Type: Article

References (28)

1. Tumors of the uterine corpus and gestational trophoblastic disease
2. Carcinoma of the lower uterine segment. Clinicopathologic analysis of 12 cases
3. Tumor of the uterine isthmus: Clinicopathologic features and immunohistochemical characterization of p53 expression and hormone receptors
4. FIGO stages - 1988 revision
5. The prognostic value of semiquantitative nuclear grading in endometrial carcinomas
6. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma
7. Tumors of the ovary maldeveloped gonads, fallopian tube, and broad ligament
8. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus
9. Reproductive, menstrual, and medical risk factors for endometrial cancer: Results from a casecontrol study
10. Risk factors among young women with endometrial cancer: A Danish case-control study
11. A case-control study on risk factors for uterine endometrial cancer in Japan
12. Subsite (cervix/endometrium)-specific risk and protective factors in uterine cancer
13. Risk factors for endometrial cancer in Japanese women
14. Endometrial carcinoma
15. Atypical polypoid adenomyoma of the uterus. A report of 27 cases
16. Atypical polypoid adenomyofibromas (atypical polypoid adenomyomas) of the uterus. A clinicopathologic study of 55 cases
17. Early invasive adenocarcinoma of the cervix. A histopathologic analysis of 40 cases with observations concerning histogenesis
18. Early adenocarcinoma of the uterine cervix
19. Early stage adenocarcinoma of the uterine cervix. Histopathologic analysis with consideration of histogenesis
20. Prevalence of human papillomavirus DNA in different histologic subtypes of cervical adenocarcinoma
21. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) study group
22. Does human papillomavirus have a role in cancers of the uterine corpus?
23. Human papilloma virus and p53 overexpression in carcinomas of the uterine cervix, lower uterine segment and endometrium
24. The frequency of p53,K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma. Evidence of distinct molecular genetic pathways
25. Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix
26. Theories of endometrial carcinogenesis: A multidisciplinary approach